References
Inaba K et al. Interstitial pneumonitis induced by pegylated liposomal doxorubicin in a patient with recurrent ovarian cancer. Med Oncol; 2011. doi:10.1007/s12032-011-9893-0.
Huober J, Schoch O, Templeton A, Spirig C, Thürlimann B. Interstitial pneumonitis after treatment with bevacizumab and pegylated liposomal doxorubicin in a patient with metastatic breast cancer. Chemotherapy. 2010;56(1):69–70.
Mirza MR, et al. A phaseII study of combination chemotherapy in early relapsed epithelial ovarian cancer using gemcitabine and pegylated liposomal doxorubicin. Gynecol Oncol. 2010;119(1):26–31.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Mark, M., Thürlimann, B. Fatal pneumonitis after treatment with pegylated liposomal doxorubicin in a patient with metastatic breast cancer in complete remission. Med Oncol 29, 1477–1478 (2012). https://doi.org/10.1007/s12032-011-0002-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12032-011-0002-1